Profile
Irving L.
Weissman is the founder of Systemix, Inc. founded in 1988.
Dr. Weissman was the founder of Forty Seven LLC founded in 2014 and served as Independent Director from 2015 to 2020.
Dr. Weissman was the founder of Cellerant Therapeutics, Inc. founded in 2003 and served as Director.
Dr. Weissman was the founder of Bitterroot Bio, Inc. founded in 2021 and served as Director.
Dr. Weissman is also the founder of Pheast Therapeutics, Inc...
Dr. Weissman is currently Director at the Institute For Stem Cell Biology & Regenerative Medicine and the Ludwig Center For Cancer Stem Cell Research & Medicine.
Dr. Weissman is a Professor at Stanford University since 1989.
Dr. Weissman is a Member of the National Academy of Sciences, the National Academy of Medicine (United States), the American Philosophical Society since 2008, the American Academy of Microbiology since 1997, and The American Association of Arts & Sciences.
Dr. Weissman is a Venture Partner at Catalio Capital Management LP.
Formerly, Dr. Weissman was Director at StemCells, Inc. from 1997 to 2016.
Dr. Weissman was an Advisor at MPM BioImpact LLC.
Dr. Weissman was a Member of the American Association for the Advancement of Science.
Dr. Weissman earned a doctorate from Stanford University in 1965 and an undergraduate degree from Montana State University in 1961.
Irving Weissman active positions
| Companies | Position | Start |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1988-12-31 |
American Philosophical Society
American Philosophical Society Miscellaneous Commercial ServicesCommercial Services Operates scholarly organization that promotes knowledge in the sciences and humanities | Corporate Officer/Principal | 2007-12-31 |
Institute For Stem Cell Biology & Regenerative Medicine | Director/Board Member | - |
Ludwig Center For Cancer Stem Cell Research & Medicine | Director/Board Member | - |
American Academy of Microbiology | Corporate Officer/Principal | 1996-12-31 |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
The American Association of Arts & Sciences | Corporate Officer/Principal | - |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Former positions of Irving Weissman
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Irving Weissman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Montana State University
Montana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services Provides science related journal, program, and education services | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Philosophical Society
American Philosophical Society Miscellaneous Commercial ServicesCommercial Services Operates scholarly organization that promotes knowledge in the sciences and humanities | Commercial Services |
American Academy of Microbiology | |
The American Association of Arts & Sciences | |
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Institute For Stem Cell Biology & Regenerative Medicine | |
Ludwig Center For Cancer Stem Cell Research & Medicine | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
Pheast Therapeutics Inc
Pheast Therapeutics Inc BiotechnologyHealth Technology Develops novel therapies in immune system to fight against cancer | Health Technology |
- Stock Market
- Insiders
- Irving Weissman
















